GS
GILEAD SCIENCES INC
GILD· Health Care· BiotechnologyS&P 500
Close · 26/10/2026
158.69
1D
+1.70%52-week range
114.02 – 160.51
Volume
60,47,200.00
Price history
GILD
25/09/2026 to 26/10/2026
O 157.62 H 159.69 L 157.52
1W+3.67%
1M+5.14%
3M+18.14%
6M+24.22%
1Y+31.43%
3Y+102.31%
5Y+140.80%
MAX+118.73%
Fundamentals
as of 26/10/2026- Market cap
- $196.77B
- Shares out
- 1.24B
- P/E (forward)
- 15.64
- EPS (trailing)
- -2.61
- Dividend yield
- 2.05%
- Beta
- 0.33
- Profit margin
- -10.64%
- P/B
- 16.63
- Return on equity
- -27.39%
SEC financial statements
67 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- GILD
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
11 filers · 2 on watchlist · 22 buys · 10 sells · 7 options · ?: 3 · D: 11 · R: 18
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 08/05/2024Thomas H TubervilleWSellGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/01/2026Josh GottheimerWBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000